MedTrace Logo

Integrative Analysis of Pulmonary Sarcomatoid Carcinoma (PSC)

NCT04215913 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-01-02

No results posted yet for this study

Summary

Integrative Analysis of pulmonary sarcomatoid carcinoma (PSC)

Conditions

Interventions

OTHER

The investigators will extract total protein, DNA and RNA from PSC patients.

The investigators will extract total protein, DNA and RNA from PSC patients.

Sponsors & Collaborators

  • The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China

    collaborator OTHER

  • Anhui Medical University

    collaborator OTHER

  • Shanghai 10th People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-30
Primary Completion
2025-12-24
Completion
2025-12-24

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215913 on ClinicalTrials.gov